<VariationArchive VariationID="2828899" VariationName="NM_001363.5(DKC1):c.5_7del (p.Ala2del)" VariationType="Deletion" Accession="VCV002828899" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2983565" VariationID="2828899">
      <GeneList>
        <Gene Symbol="DKC1" FullName="dyskerin pseudouridine synthase 1" GeneID="1736" HGNC_ID="HGNC:2890" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154762864" stop="154777689" display_start="154762864" display_stop="154777689" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153991030" stop="154005963" display_start="153991030" display_stop="154005963" Strand="+" />
          </Location>
          <OMIM>300126</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001363.5(DKC1):c.5_7del (p.Ala2del)</Name>
      <CanonicalSPDI>NC_000023.11:154762967:GGCGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154762968" stop="154762970" display_start="154762968" display_stop="154762970" variantLength="3" positionVCF="154762967" referenceAlleleVCF="TGGC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153991243" stop="153991245" display_start="153991243" display_stop="153991245" variantLength="3" positionVCF="153991242" referenceAlleleVCF="TGGC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A2del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153991245_153991247del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153991245_153991247del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154762970_154762972del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154762970_154762972del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009780.1" sequenceAccession="NG_009780" sequenceVersion="1" change="g.5215_5217del">
            <Expression>NG_009780.1:g.5215_5217del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_203300.1" sequenceAccession="NG_203300" sequenceVersion="1" change="g.426_428del">
            <Expression>NG_203300.1:g.426_428del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142463.3" sequenceAccession="NM_001142463" sequenceVersion="3" change="c.5_7del">
            <Expression>NM_001142463.3:c.5_7del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135935.1" sequenceAccession="NP_001135935" sequenceVersion="1" change="p.Ala2del">
            <Expression>NP_001135935.1:p.Ala2del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_110021.2" sequenceAccession="NR_110021" sequenceVersion="2" change="n.107_109del">
            <Expression>NR_110021.2:n.107_109del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_110022.2" sequenceAccession="NR_110022" sequenceVersion="2" change="n.107_109del">
            <Expression>NR_110022.2:n.107_109del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_110023.2" sequenceAccession="NR_110023" sequenceVersion="2" change="n.107_109del">
            <Expression>NR_110023.2:n.107_109del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001288747.2" sequenceAccession="NM_001288747" sequenceVersion="2" change="c.5_7del">
            <Expression>NM_001288747.2:c.5_7del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001275676.1" sequenceAccession="NP_001275676" sequenceVersion="1" change="p.Ala2del">
            <Expression>NP_001275676.1:p.Ala2del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363.5" sequenceAccession="NM_001363" sequenceVersion="5" change="c.5_7del" MANESelect="true">
            <Expression>NM_001363.5:c.5_7del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354.1" sequenceAccession="NP_001354" sequenceVersion="1" change="p.Ala2del">
            <Expression>NP_001354.1:p.Ala2del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_55" sequenceAccession="LRG_55">
            <Expression>LRG_55:g.5215_5217del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_55t1" sequenceAccession="LRG_55t1">
            <Expression>LRG_55t1:c.5_7del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_55p1" sequenceAccession="LRG_55p1" change="p.Ala2del">
            <Expression>LRG_55p1:p.Ala2del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001363.5(DKC1):c.5_7del (p.Ala2del) AND Dyskeratosis congenita" Accession="RCV003646411" Version="1">
        <ClassifiedConditionList TraitSetID="8154">
          <ClassifiedCondition DB="MedGen" ID="C0265965">Dyskeratosis congenita</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10364516</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11641517</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22664374</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33718801</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8154" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15989" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita</ElementValue>
                <XRef ID="Dyskeratosis+congenita/9566" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015780" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
                <XRef ID="74911008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10905" />
                <XRef ID="10905" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="1775" DB="Orphanet" />
              <XRef ID="C0265965" DB="MedGen" />
              <XRef ID="MONDO:0015780" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8217147" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="18223519|MedGen:C0265965" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004428270" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10364516</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11641517</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22664374</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33718801</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant, c.5_7del, results in the deletion of 1 amino acid(s) of the DKC1 protein (p.Ala2del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DKC1-related conditions. This variant disrupts a region of the DKC1 protein in which other variant(s) (p.Ala2Val) have been determined to be pathogenic (PMID: 10364516, 11641517, 22664374, 33718801). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DKC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153991243_153991245del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265965" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8217147" TraitType="Disease" MappingType="XRef" MappingValue="C0265965" MappingRef="MedGen">
        <MedGen CUI="C0265965" Name="Dyskeratosis congenita" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

